Compare BLTE & TGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | TGS |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.7B |
| IPO Year | 2021 | 2002 |
| Metric | BLTE | TGS |
|---|---|---|
| Price | $188.07 | $30.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $161.57 | $40.00 |
| AVG Volume (30 Days) | 176.4K | ★ 198.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.09% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $50.92 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.00 | $19.74 |
| 52 Week High | $200.00 | $34.10 |
| Indicator | BLTE | TGS |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 48.81 |
| Support Level | $148.78 | $27.94 |
| Resistance Level | $200.00 | $32.56 |
| Average True Range (ATR) | 8.11 | 1.38 |
| MACD | 0.30 | 0.01 |
| Stochastic Oscillator | 80.49 | 56.29 |
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.